Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation
10.1038/ni1387
Crossref journal-article
Springer Science and Business Media LLC
Nature Immunology (297)
Bibliography

Scheller, M., Huelsken, J., Rosenbauer, F., Taketo, M. M., Birchmeier, W., Tenen, D. G., & Leutz, A. (2006). Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation. Nature Immunology, 7(10), 1037–1047.

Authors 7
  1. Marina Scheller (first)
  2. Joerg Huelsken (additional)
  3. Frank Rosenbauer (additional)
  4. Makoto M Taketo (additional)
  5. Walter Birchmeier (additional)
  6. Daniel G Tenen (additional)
  7. Achim Leutz (additional)
References 59 Referenced 332
  1. Morrison, S.J. & Weissman, I.L. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1, 661–673 (1994). (10.1016/1074-7613(94)90037-X) / Immunity by SJ Morrison (1994)
  2. Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843–850 (2005). (10.1038/nature03319) / Nature by T Reya (2005)
  3. Staal, F.J. & Clevers, H.C. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat. Rev. Immunol. 5, 21–30 (2005). (10.1038/nri1529) / Nat. Rev. Immunol. by FJ Staal (2005)
  4. Huelsken, J. & Birchmeier, W. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 11, 547–553 (2001). (10.1016/S0959-437X(00)00231-8) / Curr. Opin. Genet. Dev. by J Huelsken (2001)
  5. Willert, K. & Nusse, R. Beta-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 8, 95–102 (1998). (10.1016/S0959-437X(98)80068-3) / Curr. Opin. Genet. Dev. by K Willert (1998)
  6. Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797–3804 (1997). (10.1093/emboj/16.13.3797) / EMBO J. by H Aberle (1997)
  7. Behrens, J. et al. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280, 596–599 (1998). (10.1126/science.280.5363.596) / Science by J Behrens (1998)
  8. Siegfried, E., Chou, T.B. & Perrimon, N. wingless signaling acts through zeste-white 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate. Cell 71, 1167–1179 (1992). (10.1016/S0092-8674(05)80065-0) / Cell by E Siegfried (1992)
  9. Wodarz, A. & Nusse, R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14, 59–88 (1998). (10.1146/annurev.cellbio.14.1.59) / Annu. Rev. Cell Dev. Biol. by A Wodarz (1998)
  10. Tamai, K. et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 407, 530–535 (2000). (10.1038/35035117) / Nature by K Tamai (2000)
  11. Behrens, J. et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638–642 (1996). (10.1038/382638a0) / Nature by J Behrens (1996)
  12. Eastman, Q. & Grosschedl, R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr. Opin. Cell Biol. 11, 233–240 (1999). (10.1016/S0955-0674(99)80031-3) / Curr. Opin. Cell Biol. by Q Eastman (1999)
  13. Morin, P.J. & Weeraratna, A.T. Wnt signaling in human cancer. Cancer Treat. Res. 115, 169–187 (2003). (10.1007/0-306-48158-8_7) / Cancer Treat. Res. by PJ Morin (2003)
  14. Taketo, M.M. Shutting down Wnt signal-activated cancer. Nat. Genet. 36, 320–322 (2004). (10.1038/ng0404-320) / Nat. Genet. by MM Taketo (2004)
  15. Giles, R.H., van Es, J.H. & Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1–24 (2003). / Biochim. Biophys. Acta by RH Giles (2003)
  16. Moon, R.T., Kohn, A.D., De Ferrari, G.V. & Kaykas, A. WNT and β-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691–701 (2004). (10.1038/nrg1427) / Nat. Rev. Genet. by RT Moon (2004)
  17. Rattis, F.M., Voermans, C. & Reya, T. Wnt signaling in the stem cell niche. Curr. Opin. Hematol. 11, 88–94 (2004). (10.1097/01.moh.0000133649.61121.ec) / Curr. Opin. Hematol. by FM Rattis (2004)
  18. Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409–414 (2003). (10.1038/nature01593) / Nature by T Reya (2003)
  19. Austin, T.W., Solar, G.P., Ziegler, F.C., Liem, L. & Matthews, W. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 89, 3624–3635 (1997). (10.1182/blood.V89.10.3624) / Blood by TW Austin (1997)
  20. Van Den Berg, D.J., Sharma, A.K., Bruno, E. & Hoffman, R. Role of members of the Wnt gene family in human hematopoiesis. Blood 92, 3189–3202 (1998). (10.1182/blood.V92.9.3189) / Blood by DJ Van Den Berg (1998)
  21. Willert, K. et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448–452 (2003). (10.1038/nature01611) / Nature by K Willert (2003)
  22. Cobas, M. β-catenin is dispensable for hematopoiesis and lymphopoiesis. J. Exp. Med. 199, 221–229 (2004). (10.1084/jem.20031615) / J. Exp. Med. by M Cobas (2004)
  23. Xu, Y., Banerjee, D., Huelsken, J., Birchmeier, W. & Sen, J.M. Deletion of β-catenin impairs T cell development. Nat. Immunol. 4, 1177–1182 (2003). (10.1038/ni1008) / Nat. Immunol. by Y Xu (2003)
  24. Verbeek, S. et al. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374, 70–74 (1995). (10.1038/374070a0) / Nature by S Verbeek (1995)
  25. Okamura, R.M. et al. Redundant regulation of T cell differentiation and TCRα gene expression by the transcription factors LEF-1 and TCF-1. Immunity 8, 11–20 (1998). (10.1016/S1074-7613(00)80454-9) / Immunity by RM Okamura (1998)
  26. Reya, T. et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13, 15–24 (2000). (10.1016/S1074-7613(00)00004-2) / Immunity by T Reya (2000)
  27. Jamieson, C.H. et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351, 657–667 (2004). (10.1056/NEJMoa040258) / N. Engl. J. Med. by CH Jamieson (2004)
  28. Harada, N. et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 18, 5931–5942 (1999). (10.1093/emboj/18.21.5931) / EMBO J. by N Harada (1999)
  29. Kuhn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427–1429 (1995). (10.1126/science.7660125) / Science by R Kuhn (1995)
  30. Adolfsson, J. et al. Upregulation of Flt3 expression within the bone marrow Lin−Sca1+c-kit+ stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15, 659–669 (2001). (10.1016/S1074-7613(01)00220-5) / Immunity by J Adolfsson (2001)
  31. Christensen, J.L. & Weissman, I.L. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98, 14541–14546 (2001). (10.1073/pnas.261562798) / Proc. Natl. Acad. Sci. USA by JL Christensen (2001)
  32. Almeida, M., Han, L., Bellido, T., Manolagas, S.C. & Kousteni, S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J. Biol. Chem. 280, 41342–41351 (2005). (10.1074/jbc.M502168200) / J. Biol. Chem. by M Almeida (2005)
  33. Kim, K., Pang, K.M., Evans, M. & Hay, E.D. Overexpression of β-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol. Biol. Cell 11, 3509–3523 (2000). (10.1091/mbc.11.10.3509) / Mol. Biol. Cell by K Kim (2000)
  34. Cheng, T. et al. Hematopoietic stem cell quiescence maintained by 21cip1/waf1. Science 287, 1804–1808 (2000). (10.1126/science.287.5459.1804) / Science by T Cheng (2000)
  35. Fleming, W.H., Alpern, E.J., Uchida, N., Ikuta, K., Spangrude, G.J. & Weissman, I.L. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J. Cell Biol. 122, 897–902 (1993). (10.1083/jcb.122.4.897) / J. Cell Biol. by WH Fleming (1993)
  36. Orschell-Traycoff, C.M. et al. Homing and engraftment potential of Sca-1+lin− cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 96, 1380–1387 (2000). (10.1182/blood.V96.4.1380) / Blood by CM Orschell-Traycoff (2000)
  37. Cheshier, S.H., Morrison, S.J., Liao, X. & Weissman, I.L. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 96, 3120–3125 (1999). (10.1073/pnas.96.6.3120) / Proc. Natl. Acad. Sci. USA by SH Cheshier (1999)
  38. Lambert, J.F.S., Forget, B.G., Weissman, S.M. & Quesenberry, P.J. et al. Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. J. Exp. Med. 197, 1563–1572 (2003). (10.1084/jem.20030031) / J. Exp. Med. by JFS Lambert (2003)
  39. Na Nakorn, T., Traver, D., Weissman, I.L. & Akashi, K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 109, 1579–1585 (2002). (10.1172/JCI0215272) / J. Clin. Invest. by T Na Nakorn (2002)
  40. Magli, M.C., Iscove, N.N. & Odartchenko, N. Transient nature of early haematopoietic spleen colonies. Nature 295, 527–529 (1982). (10.1038/295527a0) / Nature by MC Magli (1982)
  41. Socolovsky, M. et al. Ineffective erythropoiesis in Stat5a−/−5b−/− mice due to decreased survival of early erythroblasts. Blood 98, 3261–3273 (2001). (10.1182/blood.V98.12.3261) / Blood by M Socolovsky (2001)
  42. Akashi, K., Traver, D., Miyamoto, T. & Weissman, I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193–197 (2000). (10.1038/35004599) / Nature by K Akashi (2000)
  43. Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D. & Hayakawa, K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213–1225 (1991). (10.1084/jem.173.5.1213) / J. Exp. Med. by RR Hardy (1991)
  44. Rolink, A., Streb, M. & Melchers, F. The κ/λ ratio in surface immunoglobulin molecules on B lymphocytes differentiating from DHJH-rearranged murine pre-B cell clones in vitro. Eur. J. Immunol. 21, 2895–2898 (1991). (10.1002/eji.1830211137) / Eur. J. Immunol. by A Rolink (1991)
  45. Weissman, I., Spangrude, G., Heimfeld, S., Smith, L. & Uchida, N. Stem cells. Nature 353, 26 (1991). (10.1038/353026a0) / Nature by I Weissman (1991)
  46. Adolfsson, J. et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121, 295–306 (2005). (10.1016/j.cell.2005.02.013) / Cell by J Adolfsson (2005)
  47. Zeng, H., Yucel, R., Kosan, C., Klein-Hitpass, L. & Moroy, T. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J. 23, 4116–4125 (2004). (10.1038/sj.emboj.7600419) / EMBO J. by H Zeng (2004)
  48. Peled, A. et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845–848 (1999). (10.1126/science.283.5403.845) / Science by A Peled (1999)
  49. Vermeulen, M. et al. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 92, 894–900 (1998). (10.1182/blood.V92.3.894) / Blood by M Vermeulen (1998)
  50. Papayannopoulou, T., Craddock, C., Nakamoto, B., Priestley, G.V. & Wolf, N.S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc. Natl. Acad. Sci. USA 92, 9647–9651 (1995). (10.1073/pnas.92.21.9647) / Proc. Natl. Acad. Sci. USA by T Papayannopoulou (1995)
  51. Feng, Z., Srivastava, A.S., Mishra, R. & Carrier, E. A regulatory role of Wnt signaling pathway in the hematopoietic differentiation of murine embryonic stem cells. Biochem. Biophys. Res. Commun. 324, 1333–1339 (2004). (10.1016/j.bbrc.2004.09.206) / Biochem. Biophys. Res. Commun. by Z Feng (2004)
  52. Yoshida, T., Yao-Ming Ng, S., Zuniga-Pflucker, J.C. & Georgopoulos, K. Early hematopoietic lineage restrictions directed by Ikaros. Nat. Immunol. 7, 382–391 (2006). (10.1038/ni1314) / Nat. Immunol. by T Yoshida (2006)
  53. Qiang, Y.W. & Rudikoff, S. Wnt signaling in B and T lymphocytes. Front. Biosci. 9, 1000–1010 (2004). (10.2741/1309) / Front. Biosci. by YW Qiang (2004)
  54. Domen, J., Cheshier, S.H. & Weissman, I.L. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J. Exp. Med. 191, 253–264 (2000). (10.1084/jem.191.2.253) / J. Exp. Med. by J Domen (2000)
  55. Adams, J.M. et al. Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. Cold Spring Harb. Symp. Quant. Biol. 64, 351–358 (1999). (10.1101/sqb.1999.64.351) / Cold Spring Harb. Symp. Quant. Biol. by JM Adams (1999)
  56. Trowbridge, J.J., Xenocostas, A., Moon, R.T. & Bhatia, M. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat. Med. 12, 89–98 (2006). (10.1038/nm1339) / Nat. Med. by JJ Trowbridge (2006)
  57. Murdoch, B. et al. Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc. Natl. Acad. Sci. USA 100, 3422–3427 (2003). (10.1073/pnas.0130233100) / Proc. Natl. Acad. Sci. USA by B Murdoch (2003)
  58. Till, J.E. & Mc, C.E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213–222 (1961). (10.2307/3570892) / Radiat. Res. by JE Till (1961)
  59. Passegue, E. Hematopoietic stem cells, leukemic stem cells and chronic myelogenous leukemia. Cell Cycle 4, 266–268 (2005). (10.4161/cc.4.2.1489) / Cell Cycle by E Passegue (2005)
Dates
Type When
Created 19 years ago (Sept. 3, 2006, 1:44 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:46 p.m.)
Indexed 22 hours, 49 minutes ago (Sept. 3, 2025, 6:07 a.m.)
Issued 19 years ago (Sept. 3, 2006)
Published 19 years ago (Sept. 3, 2006)
Published Online 19 years ago (Sept. 3, 2006)
Published Print 18 years, 11 months ago (Oct. 1, 2006)
Funders 0

None

@article{Scheller_2006, title={Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation}, volume={7}, ISSN={1529-2916}, url={http://dx.doi.org/10.1038/ni1387}, DOI={10.1038/ni1387}, number={10}, journal={Nature Immunology}, publisher={Springer Science and Business Media LLC}, author={Scheller, Marina and Huelsken, Joerg and Rosenbauer, Frank and Taketo, Makoto M and Birchmeier, Walter and Tenen, Daniel G and Leutz, Achim}, year={2006}, month=sep, pages={1037–1047} }